维思通是近年投入临床的一种新型抗精神病药物，因其能同时改善精神分裂症的阴性、阳性症状，且锥外系反应发生较少而轻微，很快受到病人及医生的欢迎。对于维思通引起的粒细胞减少，国内外报道较少，笔者曾在临床上遇到1例，现报道如下。郝××，男，33岁，住院号：25519，因 VST is a new type of antipsychotic drug put into clinical practice in recent years. It is also welcomed by patients and doctors as it can both improve the negative and positive symptoms of schizophrenia and cause fewer and minor extrapyramidal reactions. For Vitex-induced neutropenia, less reported at home and abroad, the author once encountered in clinical cases, are reported below. Hao × ×, male, 33 years old, hospital number: 25519, due